Anhydroglucitol in Children With Type 1 Diabetes

Recruiting Observational Study
Diabetes Mellitus, Type 1
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
2 – 18
Sex
Any
Study type
Observational
Participants needed
60 (estimated)
Sponsor
University Hospital, Geneva · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The investigators will measure blood levels of 1,5-anhydroglucitol in children with type 1 diabetes and correlate them with parameters related to functional beta-cell mass in diabetic patients. The values will be compared to those obtained in healthy volunteers. Children with newly diagnosed diabetes as well as children with longstanding disease will be included. The aim of the study is to test th…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Type 1 diabetes with positive autoantibodies against islets, insulin, islet antigen 2 (IA2), glutamic acid decarboxylase (GAD) 65 or zinc transporter (ZnT)8. * Treatment with continuous subcutaneous insulin infusion (CSII) with or without automated insulin delivery (AID). * Mo…
Contacts

Philippe Klee

+41 22 372 45 90

philippe.klee@unige.ch

CONTACT

Pierre Maechler

pierre.maechler@unige.ch

CONTACT